R-Praziquantel

左旋吡喹酮

Report date: 2023/01/07 17:46:06
NME

Base Information

Drug NameR-Praziquantel
Drug Alias NameTL-010
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSchistosomiasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTongli Biomedical
China Registration ClassN/A

Develop Information

Active CompaniesTongli Biomedical
Inactive CompaniesN/A
Active IndicationsSchistosomiasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A